Long-Term Follow-Up of Allogeneic Hematopoietic Stem Cell Transplantation for Solid Cancer.

@article{Omazic2016LongTermFO,
  title={Long-Term Follow-Up of Allogeneic Hematopoietic Stem Cell Transplantation for Solid Cancer.},
  author={Brigitta Omazic and Mats Remberger and Lisbeth Barkholt and Gunnar S{\"o}derdahl and Zuzana Pot{\'a}cov{\'a} and Peter J Wers{\"a}ll and Bo-G{\"o}ran Ericzon and J. -E. Mattsson and Olle Ringd{\'e}n},
  journal={Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation},
  year={2016},
  volume={22 4},
  pages={676-681}
}
We wanted to determine whether allogeneic hematopoietic stem cell transplantation (HSCT) may result in long-term survival in patients with solid cancer. HSCT was performed in 61 patients with solid cancer: metastatic renal carcinoma (n = 22), cholangiocarcinoma (n = 17), colon carcinoma (n = 15), prostate cancer (n = 3), pancreatic adenocarcinoma (n = 3… CONTINUE READING